The purpose of this study is to evaluate the effectiveness and safety of a new pacemaker program called Atrioventricular Interval Modulation (AVIM) in patients who are schedule to have, or recently received, a pacemaker.
Contact phone
517.364.5760
Contact email
[email protected]
Principal investigator
Sparrow Clinical Research Institute
Trial Category
Heart & Vascular
Trial SubCategory
Hypertension
Webform